DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
5 articles
Lab-grown cardiac muscle is no longer just a regenerative-medicine promise: in a severe heart failure clinical trial, it showed a measurable effect on pumping function.
BioVAT is not yet a practice-changing therapy, but it goes directly at heart failure’s hardest problem: lost myocardium that does not simply grow back.
A stem-cell-based heart patch has shown an early clinical signal in one of cardiology’s hardest corners: advanced heart failure.
A major international study raises the question of whether beta blockers should still be routinely prescribed after a mild heart attack in patients with preserved heart function.
A recent study published in Nature Medicine has found that a deep learning model using smartwatch data can predict peak oxygen uptake and unplanned healthcare events in patients with heart failure.